Tag: FDA

FDA: Vascular Solutions recalls Twin-Pass Dual Access Catheters

Editor's Note The Food and Drug Administration on October 5 announced the recall by Vascular Solutions, Inc, (Minneapolis, Minnesota) of its Twin-Pass Dual Access Catheters used in catheterization procedures. The catheters have been recalled because of the potential for excess manufacturing material to remain at the tip of the catheter…

Read More

By: Judy Mathias
October 6, 2016
Share

FDA: Recall of Baxter 50 mm 0.2 micron filters

Editor's Note The Food and Drug Administration on October 3 announced the recall by Baxter International (Deerfield, Illinois) of its 50 mm 0.2 micron filters because of the potential for a missing filter support membrane and for potential presence of particulate matter. The filter is a bacteria and particulate filter…

Read More

By: Judy Mathias
October 4, 2016
Share

Joint Commission: NAN alert on medication leaking from BD syringes

Editor's Note The Joint Commission on September 28 reported on an alert the National Alert Network (NAN) issued on medications leaking from Becton-Dickinson (BD) syringes (predominantly 10 mL). Leaks have extended past the first and second rib of the stopper, and appear to occur as medication is drawn into the…

Read More

By: Judy Mathias
September 30, 2016
Share

FDA: Class I recall of DePuy Synthes power tool system battery adaptors

Editor's Note The Food and Drug Administration (FDA) on September 28 identified the recall by DePuy Synthes (a Johnson & Johnson company) of its Adaptor and Light Adaptor for Small Battery Drive and Small Battery Drive II as Class I, the most serious. The recall is due to the potential…

Read More

By: Judy Mathias
September 29, 2016
Share

FDA extends UDI compliance date for certain Class II devices

Editor's Note In a September 6 letter to device labelers, the Food and Drug Administration (FDA) said it is extending unique device identifier (UDI) requirements for certain Class II devices from September 24, 2016 to September 24, 2018. The extension applies to repackaged single-use devices and device convenience kits. The…

Read More

By: Judy Mathias
September 9, 2016
Share

FDA classifies recall of Roadrunner UniGlide Hydrophilic Wire Guides as Class I

Editor's Note The Food and Drug Administration (FDA) on September 6 classified the recall of the Roadrunner UniGlide Hydrophilic Wire Guides by Cook Medical (Bloomington, Indiana) as Class I, the most serious. All serial and lot numbers are being recalled, and the product line is being discontinued because of concern…

Read More

By: Judy Mathias
September 7, 2016
Share

FDA pulls OTC antibacterial soaps

Editor's Note The Food and Drug Administration (FDA) on September 2 issued a final rule saying that over-the-counter (OTC) antiseptic wash products containing active ingredients can no longer be marketed. The rule applies to products containing one or more of 19 ingredients, including the most commonly used triclosan and triclocarban.…

Read More

By: Judy Mathias
September 2, 2016
Share

FDA issues Safety Alert for Baxter’s Vascu-Guard patch

Editor's Note The Food and Drug Administration (FDA) on September 1 issued a Safety Alert for Baxter International’s (Deerfield, Illinois) Vascu-Guard Peripheral Vascular Patch. The FDA has received multiple adverse event reports associated with use of the Vascu-Guard patch during carotid endarterectomy, including intraoperative or postoperative bleeding and hematomas as…

Read More

By: Judy Mathias
September 1, 2016
Share

FDA advises testing of all donated blood, blood components for Zika

Editor's Note The Food and Drug Administration (FDA) on August 26 recommended testing of all donated blood and blood components for the Zika virus in the US and its territories. Because of much uncertainty about the nature and extent of Zika virus transmission, testing the entire blood supply will help…

Read More

By: Judy Mathias
August 29, 2016
Share

FDA issues Safety Alert for programmable syringe pumps

Editor's Note The Food and Drug Administration (FDA) on August 25 issued a Safety Alert for practitioners using programmable syringe pumps to infuse medications and solutions at low rates (eg, less than 5 mL/hour, and especially at less than 0.5 mL/hour). The FDA has received more than 300 reports that…

Read More

By: Judy Mathias
August 26, 2016
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat